NCT01121861 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Chang DF
Early rotational stability of the longer Staar toric intraocular lens: fifty consecutive cases. J Cataract Refract Surg. 2003 May;29(5):935-40.
Horn JD
Status of toric intraocular lenses. Curr Opin Ophthalmol. 2007 Feb;18(1):58-61. Review.
Patel CK, Ormonde S, Rosen PH, Bron AJ
Postoperative intraocular lens rotation: a randomized comparison of plate and loop haptic implants. Ophthalmology. 1999 Nov;106(11):2190-5; discussion 2196.
Sun XY, Vicary D, Montgomery P, Griffiths M
Toric intraocular lenses for correcting astigmatism in 130 eyes. Ophthalmology. 2000 Sep;107(9):1776-81; discussion 1781-2.
Till JS, Yoder PR Jr, Wilcox TK, Spielman JL
Toric intraocular lens implantation: 100 consecutive cases. J Cataract Refract Surg. 2002 Feb;28(2):295-301.

Prospective Comparative Study of the Efficacy, Predictability, Safety and Stability of the STAAR and Alcon Toric Intraocular Lenses Implanted in Asian Eyes During Phacoemulsification Surgery

Details for clinical trial NCT01121861

Clinical trial NCT01121861 - References